top of page

Search Results

Results found for "class A GPCR"

  • Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled ...

    Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled receptors expressed in tumors G protein-coupled receptors (GPCRs) are the largest family of human proteins. Because there are many more GPCRs than effectors, mutations in different receptors could perturb signaling may not be enriched within a single gene but rather that cognate mutations with similar effects on GPCR To test this possibility, we systematically aggregated somatic cancer mutations across class A GPCRs

  • Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024

    Hello GPCR Enthusiasts, Dive into this week's exciting updates on cutting-edge GPCR research, new learning And access over 500 minutes of recorded classes in our  GPCR courses with Drs. Classified GPCR News  Let’s dive into the   Classified GPCR News from September 2nd to 8th, 2024 Industry Papers Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings Insights into the structure and activation mechanism of some class B1 GPCR family members Structural

  • Functional modulation of PTH1R activation and signaling by RAMP2

    ubiquitously expressed membrane proteins that associate with different G protein–coupled receptors (GPCRs ), including the parathyroid hormone 1 receptor (PTH1R), a class B GPCR and an important modulator of These data uncover a critical role of RAMPs in the activation and signaling of a GPCR that may provide a new venue for highly specific modulation of GPCR function and advanced drug design." Read more at the source #DrGPCR #GPCR #IndustryNews

  • Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!

    Take a look at our GPCR coverage for this week. We've got 11 GPCR papers, seven industry news pieces, a new GPCR event, and even a job ad.   with real-time kinetics Discovering new ligands and GPCR behaviors for unique drug profiles   GPCR Event Let’s dive into the   Classified GPCR News  from July 29th to August 4th, 2024 GPCR Activation and Signaling GPCR Ecosystem

  • Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery

    But what are the conformation changes that drive GPCR dimerization? APJ receptors form both homodimers and heterodimers with other members of the class A GPCR family such How dynamic are GPCRs dimer interfaces? But how can we target GPCR dimers? via%3Dihub #GPCR #DrGPCR#Ecosystem

  • Understanding Enzyme Inhibition In GPCR Discovery Programs

    Enhancing scientific exploration by concentrating on understanding inhibition to advance GPCR drug discovery This Week’s GPCR Intelligence: Every drug you design will meet an enzyme before it meets its receptor mutated GPCRs. , and concise reads on β-agonists, phospho-barcodes, and GPCR allostery. The pace of GPCR innovation is accelerating.

  • 📰 GPCR Weekly News, February 20 to 26, 2023

    GPCR news content, make sure to subscribe to our monthly newsletter for Dr. GPCR News. Application of computational methods for class A GPCR Ligand discovery. Methods & Updates in GPCR Research GPCRLigNet: rapid screening for GPCR active ligands using machine Papers GPCRs: Signal Transduction. GPCR Ecosystem

  • Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools

    GPCR, the global knowledge hub for G protein-coupled receptor (GPCR) research and education, is proud GPCR. GPCR provides a unique platform to reach scientists at every stage of GPCR research,”  said Wilson Gomes GPCR Dr. GPCR is a nonprofit organization connecting the global GPCR community through training, curated news,

  • GPCR Internalization: When the Signal Moves Inside the Cell

    The Cell Surface Is Only Part of the Story For decades, GPCR pharmacology centered on events at the cell Work on receptors such as GLP-1R and MC4R has demonstrated that internalized GPCRs can continue to signal Measuring GPCR Internalization: Assay Strategies Beyond Imaging The classical approach to detecting internalization Terry Kenakin’s session on measuring GPCR internalization walks through the assay logic, the mechanistic

  • 📰 GPCR Weekly News, February 27 to March 5, 2023

    Hello Readers👋, GPCR weekly newsletter is here! GPCR Symposium event held on March 24th. GPCRs in Neuroscience Physiological Condition Dependent Changes in Ciliary GPCR Localization in the Brain Structural details of a Class B GPCR-arrestin complex revealed by genetically encoded crosslinkers in GPCR Ecosystem

  • 📰 GPCR Weekly News, May 29 to June 4, 2023

    Hello GPCR friends👋, Stay informed with the latest developments in GPCR research and industry news! GPCR Symposium is coming up on July 21st on Structural and Molecular Insights on GPCR Activation. Reviews, GPCRs, and more Advancements in G protein-coupled receptor biosensors to study GPCR-G protein Application of computational methods for class A GPCR Ligand discovery. GPCR Ecosystem

  • From GPCR Data Chaos to Decisive Action

    Is Your GPCR Program Slowing Down—Even With Good Data? You’re not alone. GPCR Ecosystem. Strong science. Promising data. But no systems to turn it into momentum. GPCR, I’m connected to 1,300+ scientists and decision-makers worldwide. Who I Work With ✅ Biotech Teams  – Especially those lacking in-house GPCR leads or overwhelmed by CRO data chaos. ✅ Venture Capital Firms  – Looking to accelerate, troubleshoot, or validate GPCR assets

  • GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions

    GPCR activation typically occurs through the binding of agonists which stabilize receptor conformations Natural and synthetic ligands can be categorized into four distinct efficacy classes: 1) full agonists GPCR targeting drugs: orthosteric vs allosteric sites Most of the drugs targeting GPCRs bind to the orthosteric GPCRs functional selectivity Recent research has revealed a more intricate understanding of GPCR behavior selectively activate specific cellular outcomes linked to that GPCR.

  • How GPCR Spatial Signaling Sparked a Scientific Journey

    Many GPCR scientists trace their origin story back to a single unexpected spark. Not a grand plan. She went from reluctant intern to global researcher shaping how we understand GPCR spatial signaling. Luck, Leadership & GPCR Signaling Michelle is clear: luck played a role. But so did choice. GPCR Podcast 🔓 Want to go deeper? Join   Dr. GPCR Premium  for exclusive tools, deep dives, and expert access.

  • How GPCR Collaboration Built an Innovation Engine

    What emerged wasn’t just another pharmacology group — it became a collaborative engine for GPCR discovery The Power of GPCR Collaboration: Funding as a Force Multiplier Collaboration sounds warm and fuzzy. This ecosystem outlasted individual PIs  and became a GPCR innovation hub  with global reach. GPCR science thrives in complexity — meaning no single lab or company can do it alone. GPCR Premium  for deep dives, strategic tools, and behind-the-scenes conversations shaping the GPCR field

  • From Pipettes to Platforms: The Evolution of GPCR Research

    That’s not a story about nostalgia — it’s a snapshot of how GPCR research was built, on technique at The Era of Cold Fingers and Patience Back then, GPCR signaling experiments weren’t elegant; they were Every step felt like it could make or break the result, The pace and precision of GPCR research today The GPCR field needs thinkers who can direct platforms, not just operate them. GPCR Podcast 🔓 Get tools, deep dives, and exclusive insights with   Dr. GPCR Premium .

  • The Truth About GPCR Product Launches: Years in the Making

    GPCR and Revvity. But there was a pivot: the tech had untapped potential for GPCRs. GPCR internalization isn’t just a trafficking readout—it’s pharmacology. GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr. GPCR Premium Ecosystem  for behind-the-scenes access to GPCR innovators, exclusive deep-dives, and practical

  • GPCR Selectivity Beyond the Receptor — Live April 9th with Bryan Roth

    GPCR community live this week to examine what happens when GPCR selectivity is encoded not at the receptor GPCR University iPSC-Derived Systems for GPCR Signaling and Translation HEK293 systems are powerful tools measurements enable comparative analysis of affinity distributions and chemical space across target classes prodrugs, biologics, irreversible inhibitors, and molecular glues — and how these unconventional ligand classes GPCR Dr. GPCR is the intelligence and community platform for GPCR scientists.

  • Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies

    The central role of GPCRs in Neurological Disorders GPCRs are the largest family of membrane receptors Over 30% of FDA-approved drugs target GPCRs, with many targeting CNS located GPCRs. GPCR Structure, Activation, and Signaling Pathways in the Brain An understanding of GPCR structure is GPCR signaling: (A) an orthosteric ligand (orange) binds an inactive GPCR, the β2 adrenergic receptor Emerging GPCR Therapeutic Targets in CNS Drug Discovery GPCRs have been studied for decades, but there

  • Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology

    In GPCR drug discovery, a single mistaken assumption can derail an entire program. Why Misreading Antagonism Delays GPCR Drug Discovery If a dose-response curve shifts to the right, you Why now:  GPCR research is accelerating—and the projects that succeed will be those built on clear, accurate Subscribe to The Kenakin Brief today  ➤   #GPCRantagonism #CompetitiveAntagonists #NonCompetitiveAntagonists DoseResponseCurve #Pharmacology #SchildEquation #AntagonistAffinity #Kinetics #DrugReceptorInteractions #GPCRblockade

  • GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery

    s latest lecture delivers high-impact insight crafted for teams navigating the complex behaviors of GPCR-targeting As Kenakin explains, all GPCR signaling is allosteric , and pretending otherwise introduces risk at every If you’re still treating GPCRs as passive targets, your screening filters may be blind to key liabilities But without understanding how GPCR state changes  influence that affinity—or vice versa—drug discovery Corner  is your trusted, expert-led guide through the evolving landscape of GPCR science.

  • Your GPCR Program Decisions Depend on Good Data Interpretation

    Welcome GPCR Fans,   In GPCR-targeted drug discovery, precision isn’t optional—it’s a requirement. GPCR Premium Members this week gain curated, early access to: Industry insights : GPCRs and mRNA in drug The interpretation of high and low affinity binding sites on GPCRs. GPCR Premium Membership Gives You an Edge Dr. GPCR Premium gives you an edge in a fast-moving field.

  • GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024

    Hello GPCR Community, Stay up-to-date with the latest GPCR research, including breakthrough studies, Lukas Grätz , Jan Voss , and Gunnar Schulte , for their study on Class-Wide Analysis of Frizzled-Dishevelled Plus, access to over 500 minutes of recorded classes of our GPCR Courses with Drs. Kenakin's upcoming classes. We’re committed to making education accessible to all! Function Delineating the stepwise millisecond allosteric activation mechanism of the class C GPCR dimer

  • Illuminating C5aR Biology: The Role of Fluorescent Ligands in GPCR Research

    GPCRs are one of the most important families of therapeutic targets in the pharmaceutical industry Approximately one-third of the drugs currently in clinical use are GPCR ligands. The C5a anaphylatoxin chemotactic receptor 1, also known as CD88, is part of the rhodopsin family of GPCRs and C5aR-Chem1 (DiscoverX) transfected cell lines, along with the cAMP HunterTM eXpress C5aR CHO-K1 GPCR Trends in GPCR Drug Discovery: New Agents, Targets and Indications.

  • Allosteric Binding Demystified: Smarter GPCR Drug Discovery

    Hello GPCR Enthusiasts, Interpreting binding data isn’t optional—it’s career-defining. GPCR Premium: Sneak Peek Every week, Premium Members get curated intelligence they won’t find in open Read the article now ➤ Discovery on Target - The Next Wave of GPCR Drug Discovery The 20th Annual GPCR-Based GPCR Premium Membership Gives You an Edge The GPCR field is advancing at breakneck speed. The pace of GPCR innovation is accelerating.

  • Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs

    GPCR University Masterclass — Integrated GPCR Discovery in Practice Dr. GPCR Masterclass ➤ Eurofins DiscoverX Partnership — Tools and Insight for GPCR Drug Discovery Modern GPCR discovery depends on more than hypotheses. GPCR Premium Membership Gives You an Edge GPCR drug discovery is accelerating — across obesity, CNS, GPCR operates as a membership-based, nonprofit initiative — built to strengthen the GPCR field through

  • Better GPCR Drug Discovery Decisions Start With Structured Learning

    If you work in GPCR research, clarity is leverage. Upcoming events: 12th Adhesion GPCR Workshop; GPCRnet International Symposium; 5th GPCRs Targeted Drug GPCR University has undergone a structural redesign. GPCR Premium Membership Gives You an Edge GPCR science is accelerating across obesity, CNS, oncology, GPCR University courses — now included in Premium.

  • Therapeutic validation of an orphan G protein‐coupled receptor

    Historically, ligands for GPCRs have been identified before their receptor counterparts. Orphan GPCRs have been shown to play key roles in various physiological functions, such as sensory perception Therefore, matching a ligand to an orphan GPCRs, the process of de-orphanizing, is of great importance GPR84 is a Gi‐coupled class A GPCR mainly expressed in immune cells and microglia in the brain (Wojciechowicz #GPCR #DrGPCR#Ecosystem

  • Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery

    Before your GPCR ligand ever meets its receptor, it meets the enzymes that determine whether it survives Discovery Program So what does that mean for discovery scientists designing the next generation of GPCR Even the most elegant GPCR ligand can fail if it never reaches its receptor. GPCR members save 50%+  with your Weekly News code. 👉 Join Terry’s Corner & Secure Your Spot for the Kenakin with your own enzyme or GPCR interaction puzzles.

  • Why Intracellular Drugs May Hold the Key to GPCR Therapeutics

    of how residence time—not potency—predicts therapeutic coverage ✅ Insight into cryptic intracellular GPCR evaluating scaffold permeability using modern, cost-effective pharmacokinetic assays   Why Intracellular GPCR Drugs Change the Game For decades, drug design has treated GPCRs as surface targets. shows how this plays out in model systems and clinical data—and why residence time should be a first-class GPCRs now have validated intracellular  allosteric sites.

bottom of page